Similar articles

• Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.

  Verschraegen C, Vinh-Hung V. Verschraegen C, et al. J Natl Cancer Inst. 2004 Jul 21;96(14):1111-2. doi: 10.1093/jnci/djh215. J Natl Cancer Inst. 2004. PMID: 15265977 No abstract available.
• Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.

  Vinh-Hung V, Verschraegen C. Vinh-Hung V, et al. J Natl Cancer Inst. 2004 Jan 21;96(2):115-21. doi: 10.1093/jnci/djh013. J Natl Cancer Inst. 2004. PMID: 14734701
• [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].

  Fodor J. Fodor J. Magy Onkol. 2009 Mar;53(1):7-14. doi: 10.1556/MOnkol.53.2009.1.2. Magy Onkol. 2009. PMID: 19318321 Hungarian.
• Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.

  Walstra CJEF, Schipper RJ, Poodt IGM, van Riet YE, Voogd AC, van der Sangen MJC, Nieuwenhuijzen GAP. Walstra CJEF, et al. Eur J Surg Oncol. 2019 Aug;45(8):1317-1327. doi: 10.1016/j.ejso.2019.02.008. Epub 2019 Feb 10. Eur J Surg Oncol. 2019. PMID: 30795956
• When may adjuvant radiotherapy be avoided in operable breast cancer?

  Kunkler IH, Prescott RJ, Williams LJ, King CC. Kunkler IH, et al. Clin Oncol (R Coll Radiol). 2006 Apr;18(3):191-9. doi: 10.1016/j.clon.2005.11.005. Clin Oncol (R Coll Radiol). 2006. PMID: 16605050 Review.